PI4KA-CLTCL1 Fusion FISH Probe
The PI4KA-CLTCL1 Fusion FISH Probe is used to confirm a fusion of the PI4KA and CLTCL1 genes. The fusion of the PI4KA and CLTCL1 genes has been associated with Skin Cutaneous Melanoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| PI4KA-CLTCL1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| PI4KA-CLTCL1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| PI4KA-CLTCL1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| PI4KA-CLTCL1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| PI4KA-CLTCL1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| PI4KA-CLTCL1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| PI4KA-CLTCL1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| PI4KA-CLTCL1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| PI4KA-CLTCL1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| PI4KA-CLTCL1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| PI4KA-CLTCL1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| PI4KA-CLTCL1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| PI4KA-CLTCL1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| PI4KA-CLTCL1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| PI4KA-CLTCL1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| PI4KA-CLTCL1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| PI4KA-CLTCL1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| PI4KA-CLTCL1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| PI4KA-CLTCL1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| PI4KA-CLTCL1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| PI4KA-CLTCL1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| PI4KA-CLTCL1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| PI4KA-CLTCL1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| PI4KA-CLTCL1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| PI4KA-CLTCL1-20-AQAQ | 20 (40 μL) | 200 μL |
|
PI4KA Gene Summary
This gene encodes a phosphatidylinositol (PI) 4-kinase which catalyzes the first committed step in the biosynthesis of phosphatidylinositol 4,5-bisphosphate. The mammalian PI 4-kinases have been classified into two types, II and III, based on their molecular mass, and modulation by detergent and adenosine. The protein encoded by this gene is a type III enzyme that is not inhibited by adenosine. [provided by RefSeq, Sep 2014]
Gene Name: Phosphatidylinositol 4-kinase Alpha
Chromosome: CHR22: 21061978 -21213070
Locus: 22q11.21
CLTCL1 Gene Summary
This gene is a member of the clathrin heavy chain family and encodes a major protein of the polyhedral coat of coated pits and vesicles. Chromosomal aberrations involving this gene are associated with meningioma, DiGeorge syndrome, and velo-cardio-facial syndrome. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2009]
Gene Name: Clathrin Heavy Chain Like 1
Chromosome: CHR22: 19166986 -19279239
Locus: 22q11.21
Gene Diseases
The PI4KA CLTCL1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Skin Cutaneous Melanoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|